Cytek Biosciences Reports Results for Quarter Ended June 30, 2026

What Happened
Cytek Biosciences, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release dated August 5, 2026. The company filed a Form 8-K (Item 2.02) to furnish that press release to the SEC; the release is attached as Exhibit 99.1 to the report.

Key Details

• Filing date: August 5, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: quarter ended June 30, 2026.
• Supporting materials: press release furnished as Exhibit 99.1; Cover Page Interactive Data File included (Inline XBRL, Exhibit 104).
• The 8-K furnishes the company’s quarterly results (earnings, revenue and related financial information) via the press release — detailed figures are in the Exhibit.

Why It Matters
This filing gives investors the company’s most recent quarterly results and any related commentary the company chose to disclose. Quarterly press releases typically include revenue, net income (or loss), and other operating metrics that can affect valuation and near-term share performance. Retail investors should review the attached press release (Exhibit 99.1) and the company’s other SEC filings or investor materials for the specific revenue, earnings, guidance, or management commentary referenced in this 8-K.